← Leaderboards
Daniel Steven Levi
University Of California Los Angeles
$836,941
Attributed
$2,618,132
Total exposure
2
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $500K · FY2009–22$500K$375K$250K$125K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$2,618,132 · 2
By mechanism
R01$1,618,132 · 1
RC1$1,000,000 · 1
Top collaborators
- Xiaochun Li4 shared
- Benjamin M Wu4 shared
- Gregory P. Carman2 shared
- David A Rigberg2 shared
- Chase Linsley1 shared
Most similar at University Of California Los Angeles
Same institution · by research overlap
- David Sigmund Liebeskind$10,675,130
- Nestor Raul Gonzalez$841,609
- David A Berry$6,302,529
- Kristina I Bostrom$17,274,164
- James C Dunn$5,407,205
Others in their field
Top investigators on “In Vivo”
- David Heimbrook · Leidos Biomedical Research, Inc.$371,850,582
- Leonard Freedman · Leidos Biomedical Research, Inc.$304,459,298
- Dennis R. Burton · Scripps Research Institute$212,708,174
- Mark S Klempner · Tufts Medical Center$128,021,180
- Florian Krammer · Icahn School Of Medicine At Mount Sinai$104,723,856
- David M. Margolis · University Of Texas Sw Med Ctr/Dallas$98,374,200
Research focus
In VivoDesignGrowthThrombosisHyperplasiaElementsFamily SuidaeFatigueInflammationStentsIn VitroCathetersCaliberBiomaterial CompatibilityBaseArtery StenosisAdultArtery OcclusionAnatomyCongenital Heart DefectsCongenital Heart DisorderChildhoodBlood VesselsAlloys
Grant awards (6)
Novel Zinc-Nanocomposite Materials for Pediatric Bioresorbable Cardiovascular Stents$429,238
R01 · FY2022 · HL
Novel Zinc-Nanocomposite Materials for Pediatric Bioresorbable Cardiovascular Stents$439,066
R01 · FY2021 · HL
Novel Zinc-Nanocomposite Materials for Pediatric Bioresorbable Cardiovascular Stents$370,443
R01 · FY2020 · HL
Novel Zinc-Nanocomposite Materials for Pediatric Bioresorbable Cardiovascular Stents$379,385
R01 · FY2019 · HL
A Novel Thin Film Nitinol Covered Stent to Treat Peripheral Arterial Disease$500,000
RC1 · FY2010 · HL
A Novel Thin Film Nitinol Covered Stent to Treat Peripheral Arterial Disease$500,000
RC1 · FY2009 · HL